feed,title,long_url,short_url
BioRxiv,SARS-CoV-2 Omicron Variant AI-based Primers,https://biorxiv.org/cgi/content/short/2022.01.21.475953v1?rss=1,https://bit.ly/3rR2p3a
BioRxiv,Structural diversity of the SARS-CoV-2 Omicron spike,https://biorxiv.org/cgi/content/short/2022.01.25.477784v1?rss=1,https://bit.ly/3u2eq8t
BioRxiv,The SARS-CoV-2 protein NSP2 impairs the microRNA-induced silencing capacity of human cells,https://biorxiv.org/cgi/content/short/2022.01.25.477753v1?rss=1,https://bit.ly/3AyljQh
BioRxiv,Despite the odds: formation of the SARS-CoV-2 methylation complex,https://biorxiv.org/cgi/content/short/2022.01.25.477673v1?rss=1,https://bit.ly/3g0NHRv
BioRxiv,Biodistribution and Environmental Safety of a Live-attenuated YF17D-vectored SARS-CoV-2 Vaccine Candidate,https://biorxiv.org/cgi/content/short/2022.01.24.477505v1?rss=1,https://bit.ly/3HaBKVh
BioRxiv,Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine,https://biorxiv.org/cgi/content/short/2022.01.25.477789v1?rss=1,https://bit.ly/3KPETw7
BioRxiv,Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability,https://biorxiv.org/cgi/content/short/2022.01.25.477770v1?rss=1,https://bit.ly/3KKHVS5
BioRxiv,Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron),https://biorxiv.org/cgi/content/short/2022.01.26.477856v1?rss=1,https://bit.ly/3rXnFE6
